Your browser doesn't support javascript.
loading
Clinical, fiscal and environmental benefits of a specialist-led virtual ureteric colic clinic: a prospective study.
Connor, Martin J; Miah, Saiful; Edison, Marie Alexandra; Brittain, James; Smith, Mitra Kondjin; Hanna, Milad; El-Husseiny, Tamer; Dasgupta, Ranan.
Afiliação
  • Connor MJ; Division of Surgery, Department of Surgery and Cancer, Imperial College London, London, UK.
  • Miah S; Department of Urology, Imperial College Healthcare NHS Trust, Charing Cross Hospital, London, UK.
  • Edison MA; Department of Urology, Imperial College Healthcare NHS Trust, Charing Cross Hospital, London, UK.
  • Brittain J; Department of Urology, Imperial College Healthcare NHS Trust, Charing Cross Hospital, London, UK.
  • Smith MK; Department of Urology, Imperial College Healthcare NHS Trust, Charing Cross Hospital, London, UK.
  • Hanna M; Department of Urology, Imperial College Healthcare NHS Trust, Charing Cross Hospital, London, UK.
  • El-Husseiny T; Department of Urology, Imperial College Healthcare NHS Trust, Charing Cross Hospital, London, UK.
  • Dasgupta R; Department of Urology, Imperial College Healthcare NHS Trust, Charing Cross Hospital, London, UK.
BJU Int ; 124(6): 1034-1039, 2019 12.
Article em En | MEDLINE | ID: mdl-31206221
ABSTRACT

OBJECTIVES:

To evaluate the clinical, fiscal and environmental impact of a specialist-led acute ureteric colic virtual clinic (VC) pathway. PATIENTS AND

METHODS:

All patients with uncomplicated acute ureteric colic, referred to a single tertiary centre, were prospectively entered into the study over a 4-year period (January 2015-December 2018). Inclusion criteria were low-dose non-contrast computed tomography of kidneys, ureters and bladder; white blood cell count <16 × 109/L; pain controlled; normal renal function; and no clinical concern. Primary outcomes were time (days) from referral to VC outcome; VC outcome (discharge, further VC, face-to-face [FTF] clinic, extracorporeal shockwave lithotripsy [ESWL], ureterorenoscopy [URS], percutaneous nephrolithotomy [PCNL]); and adverse events (sepsis or obstruction). Secondary outcomes were patient and stone demographics, cost and environmental analysis. The minimum follow-up was 3 months.

RESULTS:

A total of 1008 patients entered the study, of whom 91.5% (n = 922) were of working age. The median (interquartile range) time from presentation to VC outcome was 2 (4) days. VC outcomes were as follows 16.3% of patients (n = 164) were discharged; 18.2% (n = 183) were discharged after further VC; 17.2% (n = 173) underwent an intervention; and 48.4% (n = 488) were referred to an FTF clinic. Interventions comprised PCNL 0.5% (n = 5); ESWL 7.7% (n = 78); and URS 8.9% (n = 90). Stone demographics were as follows 570 patients (56.5%) had lower, 157 (15.6%) had upper, 96 (9.5%) had mid-ureteric and 163 (16.2%) had renal calculi, and in 22 patients (2.2%) the stones had recently passed. The mean (sd) stone size was 3.5  (2.3) mm. Two adverse events (0.2%) were reported. Introducing a VC saved £145,152 for Clinical Commissioning Groups, the equivalent NHS tariff payment of performing 106 URS procedures or 211 ureteric stent insertions. Overall, 15,085 patient journey kilometres were avoided, equal to 0.70-2.93 metric tonnes of carbon dioxide equivalent production and the need to plant 14.7 trees to achieve carbon balance.

CONCLUSION:

A specialist-led acute ureteric colic VC reduced time to treatment decision to a median of 2 days. This creates additional clinic capacity and reduces the fiscal burden of traditional clinics and their associated carbon footprint.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Telemedicina / Cólica Renal / Pegada de Carbono Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Telemedicina / Cólica Renal / Pegada de Carbono Idioma: En Ano de publicação: 2019 Tipo de documento: Article